Access to SYN023 for rabies treatment program
Part of Infections clinical trials.
This program provides access to an experimental rabies treatment called SYN023 for people who cannot get other treatments. It might help if standard options are not available or suitable for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You cannot get or are not eligible for other approved or experimental rabies treatments.
- There are no other available treatments that could cure your condition.
- Your doctor will check if this treatment is safe for you based on your specific health situation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new rabies vaccine to see how well it works and if it is safe for people who have not been exposed to rabies. It may be a good option if you want protection before potential exposure.
This trial tests if a rabies vaccine given as a small injection into the skin works as well as the standard shot into muscle. It may mean fewer side effects and use less vaccine.
This study tests different doses of an experimental rabies vaccine to see which dose works best and is safest. It is for healthy adults who have never had a rabies shot before and are not at recent risk of rabies exposure.
This trial tests a new freeze-dried rabies vaccine made from human cells. It is for people who may need protection against rabies after a possible exposure, and the study will compare it to standard rabies vaccines.
This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.
This trial tests if a new experimental rabies vaccine (ChAdOx2 RabG) can be safely given together with the regular rabies vaccine. Healthy adults aged 18–45 may join to help see if the combination works and is safe.
Hear when a new Rabies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.